Identification of Novel Tubulin Dimer Inhibitors for Pancreatic Cancer: An Integrated Computational Approach
Preprint
- 5 November 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
Pancreatic cancer remains one of the most lethal malignancies, with mortality rates exceeding 90% in males and 89% in females, largely due to late-stage diagnosis and chemotherapy resistance. Despite advances in cancer research, effective treatment options for pancreatic cancer remain limited, highlighting the urgent need for novel therapeutic strategies. Identification of potent tubulin dimer inhibitors, disrupting the Alpha-Beta dimer complex essential for microtubule dynamics and cancer cell proliferation, offers a promising therapeutic avenue. Computational drug discovery provides an effective strategy to find novel inhibitors with enhanced binding efficiency, stability, and adaptability for personalized treatments. We implemented a multi-faceted computational approach combining molecular docking, density functional theory (DFT), molecular dynamics (MD) simulations, and principal component analysis (PCA). DrugBank screening identified Bisphosphonate-8 and Fenoldopam as potential inhibitors, with Paclitaxel as a reference drug. DFT calculations provided quantum mechanical insights into ligand-tubulin interactions, while binding energy analysis revealed Bisphosphonate-8 exhibiting a nearly 2-fold higher binding affinity than Paclitaxel. Microsecond-scale MD simulations assessed the stability and flexibility of ligand-protein complexes, and PCA analysis of MD simulations trajectories demonstrated significant conformational adaptability, reinforcing the potential of Bisphosphonate-8 and Fenoldopam as effective tubulin dimer inhibitors. Bisphosphonate-8, demonstrating superior binding properties in silico, emerges as a promising candidate for preclinical evaluation in pancreatic cancer, offering translational potential for improved targeted therapy.Keywords
All Related Versions
This publication has 72 references indexed in Scilit:
- Trends in the Global Incidence of Pancreatic Cancer and a Brief Review of its Histologic and Molecular SubtypesJournal of Gastrointestinal Cancer, 2025
- Comprehensive Analysis of Binding Sites in TubulinAngewandte Chemie International Edition, 2021
- Limb-salvage surgery offers better five-year survival rate than amputation in patients with limb osteosarcoma treated with neoadjuvant chemotherapy. A systematic review and meta-analysisJournal of Bone Oncology, 2020
- Molecular mechanisms of action of bisphosphonates and new insights into their effects outside the skeletonBone, 2020
- Microtubule-targeting agents and their impact on cancer treatmentEuropean Journal of Cell Biology, 2020
- Current advances of tubulin inhibitors as dual acting small molecules for cancer therapyMedicinal Research Reviews, 2019
- Pancreatic Cancer: Current Status and ChallengesCurrent Pharmacology Reports, 2017
- Trajectories of microsecond molecular dynamics simulations of nucleosomes and nucleosome core particlesData in Brief, 2016
- Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichmentsJournal of Computer-Aided Molecular Design, 2013
- The molecular basis of multidrug resistance in cancer: The early years of P‐glycoprotein researchFEBS Letters, 2005